Paoli, PA, United States of America

Mohit Trikha

USPTO Granted Patents = 11 



Average Co-Inventor Count = 4.1

ph-index = 7

Forward Citations = 498(Granted Patents)


Location History:

  • Paoli, PA (US) (2007 - 2011)
  • San Mateo, CA (US) (2013)

Company Filing History:


Years Active: 2007-2013

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Journey of Mohit Trikha

Introduction: Mohit Trikha, an esteemed inventor based in Paoli, PA, has made significant contributions to the field of biotechnology, particularly with his focus on anti-integrin antibodies. With a total of nine patents to his name, Trikha's work reflects a commitment to advancing therapeutic methods and compositions that have the potential to transform healthcare.

Latest Patents: Among his recent innovations are two notable patents related to anti-integrin antibodies. The first patent focuses on novel anti-alpha-V subunit antibodies, encompassing isolated nucleic acids that encode these antibodies, as well as vectors, host cells, transgenic animals, and plants. This invention not only highlights the complexities of his research but also offers pathways for therapeutic applications. These patents cover methods of making and using these antibodies, intended for developing advanced therapeutic compositions and devices.

Career Highlights: Mohit Trikha currently works at Centocor, Inc., a biotechnology company renowned for its work in the development of medical devices and therapeutic products. His contributions have not only advanced the company's research objectives but have also positioned him as an influential figure in his field. The breadth of his patents indicates his active role in pushing the boundaries of current scientific knowledge.

Collaborations: Throughout his career, Trikha has collaborated with talented professionals, including Jill M. Giles-Komar and Linda Snyder. These partnerships exemplify the collaborative spirit in the field of innovation and highlight how teamwork is integral to scientific advancements.

Conclusion: Mohit Trikha's innovative work in the area of anti-integrin antibodies positions him as a leading inventor in biotechnology. With nine patents and a dedicated approach to research, he exemplifies how creativity and collaboration can lead to significant advancements that have the potential to enhance therapeutic outcomes. His journey is a testament to the power of innovation in shaping the future of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…